Discovery and Preclinical Research
Arlenda has a long expertise in supporting discovery laboratories in pharmaceutical sciences with great emphasis on in-vitro and in-vivo animal models to ensure the studies are adequately reproducible and predictive to support decision making.
- Statistics for the development and qualification of bioassays
- Statistics for the development of in-vivo and pharmacology models
- Development of biomarkers
- Therapeutic areas
Arlenda is specialized in the development and analyses of innovative clinical trials to maximize the probability of success and the outcome.
- Protocol and SAP development
- Contribution to CSR and submission
- Pediatric development, rare and orphan disease
- Biomarker qualification
- Analyses of complex data and signals
- Pharmacovigilance and recruitment
Since its creation in 2003, Arlenda has built a recognized and innovative expertise in the development, validation and control of analytical procedures and bioassays.
- Analytical procedures
Process Design and Manufacturing
Arlenda has developed a long experience in proposing robust and innovative statistical solutions for the development, validation and control of processes, in particular bio-processes for mABs, vaccines and cell cultures.
- Lifecycle and Quality by Design methodology
- Continuous manufacturing
Data Science and Big Data
Arlenda has a wide range of experts in mathematics, Bayesian statistics, computational science, chemistry, biology, pharmacy, bio- engineer, biochemistry, business and psychology that can, by working together, address, solve and implement impactful data science solutions for a wide range of problems.
- Examples of applications by Arlenda
Arlenda Liège Office (Belgium) Avenue du Parc Industriel, 89 4041 Milmort Belgium Phone: +32 10 46 10 10
Arlenda, Inc. (U.S.) 128 Orchard Way, Berwyn, PA 19312 USA Phone: +1 (908) 3462181
RECENT NEWS & EVENTS
December 4-6, 2017 The laboratory landscape continues to face an influx of regulations surrounding the reliability, consistency and accuracy of analytical methods and data. From FDA’s final guidance on analytical procedures to USP chapter updates to FDA and MHRA’s...